Qiu P - Search Results

1

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M, Zhang Q, Xu Y. Sun X, et al. Among authors: qiu p. Int Immunopharmacol. 2021 Dec;101(Pt B):108275. doi: 10.1016/j.intimp.2021.108275. Epub 2021 Oct 21. Int Immunopharmacol. 2021. PMID: 34688153

2

[Discussion on the indications of internal mammary sentinel lymph node biopsy in breast cancer in the era of precision medicine].

Wang YS, Zhao RR, Liu YB, Chen P, Zhao T, Sun X, Wang CJ, Zhang ZP, Shi ZQ, Qiu PF. Wang YS, et al. Among authors: qiu pf. Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):251-256. doi: 10.3760/cma.j.issn.0253-3766.2019.04.003. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31014049 Chinese.

3

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy.

Tan S, Fu X, Xu S, Qiu P, Lv Z, Xu Y, Zhang Q. Tan S, et al. Among authors: qiu p. Pathol Oncol Res. 2021 Dec 20;27:1609972. doi: 10.3389/pore.2021.1609972. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34987312 Free PMC article.

4

Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity.

Sun X, Liu X, Yu K, Xu S, Qiu P, Lv Z, Zhang X, Xu Y. Sun X, et al. Among authors: qiu p. J Cancer Res Clin Oncol. 2022 Apr;148(4):767-774. doi: 10.1007/s00432-021-03912-z. Epub 2022 Jan 15. J Cancer Res Clin Oncol. 2022. PMID: 35032216 Review.

5

Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.

Chen Y, Liu X, Yu K, Sun X, Xu S, Qiu P, Lv Z, Zhang X, Guo A, Xu Y. Chen Y, et al. Among authors: qiu p. Ann Transl Med. 2022 Jan;10(2):93. doi: 10.21037/atm-21-6924. Ann Transl Med. 2022. PMID: 35282081 Free PMC article.

6

A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer.

Wang Y, Liu X, Yu K, Xu S, Qiu P, Zhang X, Wang M, Xu Y. Wang Y, et al. Among authors: qiu p. iScience. 2023 Mar 2;26(4):106330. doi: 10.1016/j.isci.2023.106330. eCollection 2023 Apr 21. iScience. 2023. PMID: 36950120 Free PMC article.

7

A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity.

Wang Y, Wang M, Yu K, Xu S, Qiu P, Lyu Z, Cui M, Zhang Q, Xu Y. Wang Y, et al. Among authors: qiu p. Cancer Biol Med. 2023 Mar 24;20(3):218-28. doi: 10.20892/j.issn.2095-3941.2022.0513. Cancer Biol Med. 2023. PMID: 36971132 Free PMC article.

8

Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study.

Yao L, Liu X, Wang M, Yu K, Xu S, Qiu P, Lv Z, Zhang X, Xu Y. Yao L, et al. Among authors: qiu p. J Breast Cancer. 2023 Apr;26(2):136-151. doi: 10.4048/jbc.2023.26.e12. Epub 2023 Mar 16. J Breast Cancer. 2023. PMID: 37051647 Free PMC article.

9

Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors.

Chen X, Wang M, Yu K, Xu S, Qiu P, Lyu Z, Zhang X, Xu Y. Chen X, et al. Among authors: qiu p. J Transl Int Med. 2022 Mar 5;11(3):226-233. doi: 10.2478/jtim-2021-0050. eCollection 2023 Sep. J Transl Int Med. 2022. PMID: 37662890 Free PMC article.

10

Development and validation of a nomogram for predicting internal mammary sentinel node metastasis in breast cancer patients.

Qiu PF, Lv Q, Zhao WH, Huang YX, Zhu SG, Zhong H, Yang GL, Bell S, Wang LY, Xu YY, Sun X, Chen YG, Ding Q, Wang YS. Qiu PF, et al. Eur J Surg Oncol. 2023 Oct;49(10):107040. doi: 10.1016/j.ejso.2023.107040. Epub 2023 Aug 22. Eur J Surg Oncol. 2023. PMID: 37672825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,471 results

Search Page

Filters